Helicobacter pylori and stomach cancer in the French West Indies

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers at CHU Martinique will enroll adults referred for endoscopy with a newly diagnosed primary gastric cancer and obtain consent to use leftover diagnostic tissue and serum. Biopsy samples, adjacent healthy tissue, and blood will be tested for Helicobacter pylori and stored in a biobank. The study will estimate H. pylori prevalence among these cancer patients and create materials for later etiological studies, including investigations of environmental pollutant exposures. Results aim to fill regional data gaps about drivers of the higher gastric cancer rates observed in the French West Indies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patient over 18 years of age, residing for at least 6 months in Martinique, with a primary diagnosis of gastric cancer
2. Patient having read the information note and having signed the consent to participate in the study
3. Patient with social security coverage

Exclusion Criteria:

1. Refusal to participate
2. Patient who could not answer the questionnaires
3. Patient not affiliated to a social security system
4. Patient not fluent in French
5. Patient under legal protection (legal protection, guardianship, curators, etc.)

Where it's running

• CHU Martinique
  Fort-de-France, Martinique Recruiting

Study contacts

• Principal investigator: Clarisse JOACHIM-CONTARET — CHU Martinique
• Study coordinator: Clarisse JOACHIM-CONTARET
• Email: clarisse.joachim@chu-martinique.fr
• Phone: +596596559674

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Candonilimab with Fruquintinib and Paclitaxel Albumin-Bound as second-line treatment for advanced gastric cancer

  This phase 2 trial tests whether adding candonilimab to fruquintinib and nab-paclitaxel helps people with advanced gastric or gastroesophageal junction cancer who progressed after first-line therapy.

  Recruiting Phase 2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07920224

• Epinephrine concentrations during gastric submucosal dissection in adults with gastric neoplasia

  This trial tests whether a lower dose of epinephrine (1:100,000) during gastric ESD works as well as a higher dose (1:500,000) to keep procedures efficient and safe in adults with gastric dysplasia or neoplasia.

  Recruiting Unidade Local de Saúde do Alto Ave, EPE · Guimarães, Braga District · NCT07920068

• TEAS after gastrectomy to aid recovery after laparoscopic stomach cancer surgery

  A randomized trial tests whether transcutaneous electrical acupoint stimulation (TEAS) after laparoscopic gastrectomy helps people recover faster and with less pain compared with a sham treatment.

  Recruiting at 8 sites The Affiliated Hospital of Qingdao University · Qingdao, Shandong and 7 other locations · NCT07898293

• Maintenance therapy in metastatic gastric cancer: a multicenter look from Colombia

  This study reviews medical records of adults with metastatic gastric cancer in Colombia to see how patients fare after starting maintenance therapy following initial chemotherapy.

  Recruiting at 4 sites Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. and 3 other locations · NCT07856212

• Stomach-Partitioning Surgery to Help Block Obstruction in Advanced Stomach Cancer

  This trial tests whether stomach-partitioning gastrojejunostomy helps people with unresectable, advanced stomach cancer better tolerate food after surgery than the standard approach.

  Recruiting Gyeongsang National University Hospital · Changwon, Gyeongsangnam-do · NCT07749326

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.